Abstract
Assessment of Tumor Lysis Syndrome in Patients with Chronic Lymphocytic Leukemia Treated with Venetoclax in the Clinical Trial and Post-Marketing Settings
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have